Twin Tree Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.26M | Sell |
23,400
-126,600
| -84% | -$17.7M | 0.07% | 325 |
|
|
2025
Q4 | $18.4M | Sell |
150,000
-25,500
| -15% | -$3.1M | 0.16% | 146 |
|
|
2025
Q3 | $19.5M | Buy |
175,500
+111,900
| +176% | +$12.7M | 0.08% | 292 |
|
|
2025
Q2 | $7.05M | Buy |
+63,600
| New | +$6.77M | 0.01% | 894 |
|
|
2025
Q1 | – | Sell |
-63,600
| Closed | -$5.87M | – | 1690 |
|
|
2024
Q4 | $5.87M | Sell |
63,600
-992,700
| -94% | -$89.4M | 0.01% | 880 |
|
|
2024
Q3 | $88.6M | Buy |
1,056,300
+679,400
| +180% | +$51.8M | 0.17% | 88 |
|
|
2024
Q2 | $25.9M | Sell |
376,900
-250,000
| -40% | -$16.7M | 0.06% | 303 |
|
|
2024
Q1 | $45.9M | Buy |
+626,900
| New | +$48.2M | 0.1% | 197 |
|
|
2022
Q2 | – | Sell |
-161,500
| Closed | -$9.6M | – | 1622 |
|
|
2022
Q1 | $9.6M | Buy |
+161,500
| New | +$10.3M | 0.02% | 708 |
|
|
2021
Q2 | – | Sell |
-257,500
| Closed | -$16.6M | – | 1449 |
|
|
2021
Q1 | $16.6M | Sell |
257,500
-652,200
| -72% | -$42.1M | 0.06% | 321 |
|
|
2020
Q4 | $53M | Sell |
909,700
-790,300
| -46% | -$47.7M | 0.21% | 118 |
|
|
2020
Q3 | $107M | Sell |
1,700,000
-43,200
| -2% | -$3M | 0.44% | 36 |
|
|
2020
Q2 | $134M | Buy |
+1,743,200
| New | +$134M | 0.55% | 15 |
|
|
2019
Q3 | – | Sell |
-15,300
| Closed | -$1.03M | – | 1319 |
|
|
2019
Q2 | $1.03M | Hold |
15,300
| – | – | 0.01% | 792 |
|
|
2019
Q1 | $995K | Sell |
15,300
-47,400
| -76% | -$3.15M | 0.01% | 826 |
|
|
2018
Q4 | $3.92M | Buy |
+62,700
| New | +$4.38M | 0.02% | 550 |
|
|
2018
Q3 | – | Sell |
-180,500
| Closed | -$12.8M | – | 1138 |
|
|
2018
Q2 | $12.8M | Sell |
180,500
-186,600
| -51% | -$13.2M | 0.08% | 217 |
|
|
2018
Q1 | $27.7M | Buy |
367,100
+294,600
| +406% | +$23.4M | 0.22% | 61 |
|
|
2017
Q4 | $5.19M | Sell |
72,500
-79,200
| -52% | -$6.01M | 0.04% | 387 |
|
|
2017
Q3 | $12.3M | Sell |
151,700
-58,400
| -28% | -$4.47M | 0.1% | 197 |
|
|
2017
Q2 | $14.9M | Buy |
210,100
+31,500
| +18% | +$2.1M | 0.12% | 171 |
|
|
2017
Q1 | $12.1M | Sell |
178,600
-64,100
| -26% | -$4.51M | 0.11% | 189 |
|
|
2016
Q4 | $17.4M | Sell |
242,700
-9,000
| -4% | -$669K | 0.17% | 141 |
|
|
2016
Q3 | $19.9M | Buy |
251,700
+64,700
| +35% | +$5.26M | 0.25% | 76 |
|
|
2016
Q2 | $15.6M | Buy |
187,000
+16,500
| +10% | +$1.46M | 0.24% | 80 |
|
|
2016
Q1 | $15.7M | Buy |
170,500
+30,100
| +21% | +$2.71M | 0.3% | 60 |
|
|
2015
Q4 | $14.2M | Buy |
140,400
+2,900
| +2% | +$302K | 0.28% | 57 |
|
|
2015
Q3 | $13.5M | Sell |
137,500
-145,300
| -51% | -$16.1M | 0.35% | 35 |
|
|
2015
Q2 | $33.1M | Buy |
282,800
+73,400
| +35% | +$8.02M | 0.8% | 8 |
|
|
2015
Q1 | $20.5M | Buy |
209,400
+40,900
| +24% | +$4.15M | 0.53% | 21 |
|
|
2014
Q4 | $15.9M | Buy |
168,500
+37,400
| +29% | +$3.87M | 0.44% | 28 |
|
|
2014
Q3 | $14M | Sell |
131,100
-289,200
| -69% | -$28.3M | 0.37% | 35 |
|
|
2014
Q2 | $34.8M | Buy |
420,300
+378,900
| +915% | +$29.5M | 0.78% | 9 |
|
|
2014
Q1 | $2.93M | Sell |
41,400
-74,300
| -64% | -$5.83M | 0.06% | 353 |
|
|
2013
Q4 | $8.69M | Buy |
115,700
+58,300
| +102% | +$4.06M | 0.21% | 77 |
|
|
2013
Q3 | $3.61M | Sell |
57,400
-32,700
| -36% | -$1.95M | 0.12% | 181 |
|
|
2013
Q2 | $4.62M | Buy |
+90,100
| New | +$4.7M | 0.18% | 107 |
|
Other funds holding GILD
VCM
VPM
Twin Tree Management's GILD Position: Q4 2024 in Review
Twin Tree Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 513,621 shares — an estimated $46.2M sold.
Twin Tree Management first reported a position in GILD in Q3 2013 and held it in 37 quarters. The position peaked at $43.1M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Twin Tree Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
- Twin Tree Management sold 513,621 Gilead Sciences shares in Q4 2024, an estimated $46.2M.
- Twin Tree Management first reported a position in Gilead Sciences in Q3 2013 and held it in 37 quarters.
- Twin Tree Management's Gilead Sciences position peaked at $43.1M in Q3 2024.
- 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Twin Tree Management's 13F filing for Q4 2024, filed 10 Feb 2025.